Rhythm Pharmaceuticals annual capital expenditures (capex)
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Rhythm Pharmaceuticals Capital Expenditures (CapEx) Growth & History (RYTM)
Rhythm Pharmaceuticals's capital expenditures (capex) was $953,000 for fiscal 2025.
View full Rhythm Pharmaceuticals company overviewRhythm Pharmaceuticals annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $953,000 | $953,000 | — |
| 2024 | 2024-12-31 | $0 | −$47,000 | — |
| 2023 | 2023-12-31 | $47,000 | −$234,000 | −83.27% |
| 2022 | 2022-12-31 | $281,000 | −$153,000 | −35.25% |
| 2021 | 2021-12-31 | $434,000 | $220,000 | +102.80% |
| 2020 | 2020-12-31 | $214,000 | −$3.2M | −93.68% |
| 2019 | 2019-12-31 | $3.4M | $2.7M | +368.84% |
| 2018 | 2018-12-31 | $722,000 | $589,000 | +442.86% |
| 2017 | 2017-12-31 | $133,000 | −$924,000 | −87.42% |
| 2016 | 2016-12-31 | $1.1M | $1.0M | +6117.65% |
| 2015 | 2015-12-31 | $17,000 | — | — |
Rhythm Pharmaceuticals quarterly capital expenditures (capex)
Q3.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | $40.5M | $40.5M | +4049900.00% |
| Q3 2024 | 2024-09-30 | $500,000 | $499,000 | +49900.00% |
| Q2 2024 | 2024-06-30 | $0 | $0 | — |
| Q1 2024 | 2024-03-31 | $40.0M | $40.0M | +85006.38% |
| Q4 2023 | 2023-12-31 | $1,000 | $0 | 0.00% |
| Q3 2023 | 2023-09-30 | $1,000 | −$94,000 | −98.95% |
| Q2 2023 | 2023-06-30 | $0 | −$60,000 | — |
| Q1 2023 | 2023-03-31 | $47,000 | −$80,000 | −62.99% |
| Q4 2022 | 2022-12-31 | $1,000 | −$67,000 | −98.53% |
| Q3 2022 | 2022-09-30 | $95,000 | −$11,000 | −10.38% |
| Q2 2022 | 2022-06-30 | $60,000 | −$188,000 | −75.81% |
| Q1 2022 | 2022-03-31 | $127,000 | $115,000 | +958.33% |
| Q4 2021 | 2021-12-31 | $68,000 | — | — |
| Q3 2021 | 2021-09-30 | $106,000 | — | — |
| Q2 2021 | 2021-06-30 | $248,000 | — | — |
| Q1 2021 | 2021-03-31 | $12,000 | — | — |
| Q4 2019 | 2019-12-31 | $0 | — | — |
| Q3 2019 | 2019-09-30 | $259,000 | −$58,000 | −18.30% |
| Q2 2019 | 2019-06-30 | $2.3M | — | — |
| Q1 2019 | 2019-03-31 | $811,000 | — | — |
| Q3 2018 | 2018-09-30 | $317,000 | — | — |
Rhythm Pharmaceuticals capital expenditures (capex) trends
Over the last five fiscal years, Rhythm Pharmaceuticals's capital expenditures (capex) increased from $214,000 to $953,000, a change of $739,000. The latest reported quarter, Q4 2024, shows $40.5M.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Rhythm Pharmaceuticals source filings ↗